Immunohistochemistry results unveiled a remarkable reduction of ACSS2 and Pan‐Kcr protein levels in IBD patients (Figure 1G,H), which was negatively associated with disease severity (Figure S1F–I, Supporting Information). Here, CLEC4F is linked to inflammatory bowel disease.